D
Eton Pharmaceuticals, Inc. ETON
$14.99 -$0.28-1.83% NASDAQ
Recommendation
Prev Close
$14.99
Volume
153,751
Avg Vol (90D)
281,545
Market Cap
$401.99M
Dividend & Yield
--
52-Week Range
$11.09 - $23.00
P/E (TTM)
--
EPS (TTM)
-$0.26
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Eton Pharmaceuticals: An Undervalued Small Cap With High Growth
1/23/2026 - Seeking Alpha - Long Ideas
Eton Pharmaceuticals: An Undervalued Small Cap With High Growth
1/23/2026 - SeekingAlpha
Brokerages Set Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Price Target at $29.67
1/20/2026 - Ticker Report
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Given Average Recommendation of "Hold" by Brokerages
1/17/2026 - MarketBeat
Eton Pharmaceuticals (ETON, $15.46) Moving Average Convergence Divergence (MACD) Histogram turned negative on January 9, 2026
1/10/2026 - Tickeron - Stocks
Eton Pharmaceuticals (ETON, $15.46) price may climb as it broke lower Bollinger Band on Jan 09, 2026
1/10/2026 - Tickeron - Stocks
Eton Pharmaceuticals (ETON, $16.51) entered Downtrend as Momentum indicator drops below 0 level on Jan 07, 2026
1/8/2026 - Tickeron - Stocks
Eton Pharmaceuticals (NASDAQ:ETON) Upgraded at Zacks Research
1/3/2026 - MarketBeat
Eton Pharmaceuticals Breaks Below 200-Day Moving Average - Notable for ETON
1/2/2026 - Market News Video
Eton Pharmaceuticals (ETON, $16.83) entered Downtrend as Momentum indicator drops below 0 level on Dec 26, 2025
12/27/2025 - Tickeron - Stocks
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Receives Average Rating of "Hold" from Brokerages
12/23/2025 - MarketBeat
Eton Pharmaceuticals (ETON, $15.82) entered Downtrend as Momentum indicator drops below 0 level on Dec 17, 2025
12/18/2025 - Tickeron - Stocks
Eton Pharmaceuticals (NASDAQ:ETON) Downgraded by Wall Street Zen to Hold
12/13/2025 - MarketBeat
What is HC Wainwright's Estimate for ETON FY2025 Earnings?
12/11/2025 - MarketBeat
Q4 EPS Forecast for Eton Pharmaceuticals Lowered by Analyst
12/10/2025 - MarketBeat
Divisadero Street Capital Management LP Purchases New Holdings in Eton Pharmaceuticals, Inc. $ETON
12/8/2025 - MarketBeat
Eton Pharmaceuticals (ETON, $16.81) Moving Average Convergence Divergence (MACD) Histogram turned positive on December 4, 2025
12/5/2025 - Tickeron - Stocks
Geode Capital Management LLC Has $8.45 Million Stock Position in Eton Pharmaceuticals, Inc. $ETON
12/5/2025 - MarketBeat
Diametric Capital LP Increases Stock Holdings in Eton Pharmaceuticals, Inc. $ETON
12/5/2025 - MarketBeat
Eton Pharmaceuticals (ETON, $16.5) RSI Indicator left the oversold zone on December 03, 2025
12/5/2025 - Tickeron - Technical Analysis
Implied Volatility Surging for Eton Pharmaceuticals Stock Options
12/4/2025 - Zacks Investment Research
ETON Makes Bullish Cross Above Critical Moving Average
12/4/2025 - Market News Video
Eton Pharmaceuticals management to meet with B. Riley
12/3/2025 - The Fly
Eton Pharmaceuticals (ETON, $15.45) RSI Indicator left the oversold zone on December 01, 2025
12/2/2025 - Tickeron - Stocks
Eton Pharmaceuticals management to meet with B. Riley
12/1/2025 - The Fly
Income Statement
Total Revenue (TTM)
$70.32M
EBITDA (TTM)
$3.58M
EBIT (TTM)
$267.00K
Net Income (TTM)
-$6.68M
Balance Sheet
Total Assets (Q)
$104.51M
Total Debt (Q)
$30.88M
Total Liabilities (Q)
$81.38M
Book Value Per Share (Q)
$0.8623
Cash Flow
Cash from Operations (TTM)
$21.31M
Cash from Investing (TTM)
-$38.42M
Cash from Financing (TTM)
$33.97M
Net Change in Cash (TTM)
$16.86M
Filings
Filing Date
Thursday, November 6, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Mar 16 and 20 (est)
Price History
Loading...
Beta
1.27
7-Day Total Return
-4.34%
30-Day Total Return
-8.65%
60-Day Total Return
-19.41%
90-Day Total Return
-14.64%
Year to Date Total Return
-7.81%
1-Year Total Return
-10.08%
2-Year Total Return
236.85%
3-Year Total Return
321.07%
5-Year Total Return
65.82%
52-week Low
Apr 07, 2025 - $11.09
52-week High
Sep 30, 2025 - $23.00
Valuation
Market Cap
$401.99M - Small Cap
Enterprise Value
$395.75M
Price/Sales (TTM)
5.73
Price/Book (Q)
17.38
Dividends and Shares
Shares Outstanding
26.89M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.etonpharma.com
Phone Number
847 787 7361
Address
21925 W. Field Parkway
Deer Park, IL 60010-7278
Country
United States
Year Founded
2017
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the... more
NASDAQ 01/23/2026 4:00PM Eastern Quotes delayed